F8 and hemophilia A: To test the hypothesis that F8‐modified ProliHHs have therapeutic potential for the treatment of haemophilia A, we first confirmed that PHHs and ProliHHs do not express F8 through analysis of cellular transcriptional profiling (Figure S1A), which was a prerequisite for the F8‐modified ProliHH therapy.